Search Results 531-540 of 3106 for Mão Morta de Volkmann

1. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) in Women with Recurrent, Persistent or Metastatic Endometrial Cancer. A Multi-Arm Trial for Women with Recurrent or Persistent Endometrial Cancer” - Mayo Clinic

   Olaparib, cediranib maleate, and Wee1 inhibitor AZD1775 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation ...

2. Overview - Molecular Mechanisms of Tumorigenesis: Verline Justilien - Mayo Clinic Research

   In her Molecular Mechanisms of Tumorigenesis Lab at Mayo Clinic, Verline Justilien, Ph.D., hopes to identify oncogenic drivers of lung cancer and pancreas ...

3. Maria I. Vazquez Roque, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

   In 2008 she finished her internal medicine residency in Puerto Rico. She then pursued a Gastroenterology fellowship in the NIH training grant at Mayo Clinic ...

4. Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab and ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.

5. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer - Mayo Clinic

   About this study. The purpose of these phase I/II trial studies is to analyze the side effects and best dose of liposomal irinotecan and rucaparib when ...

6. The Development of a Shared Decision Making Encounter Tool for Bone Health Management Decisions - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. The MOTS (Medication Overuse Treatment Strategy) Trial - Mayo Clinic

   There are two commonly used treatment strategies for treating patients who have chronic migraine with medication overuse. This study will compare the outcomes ...

8. A Study to Evaluate the Effectiveness and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides - Mayo Clinic

   Cobomarsen is designed to inhibit the activity of a molecule called miR-155 that may be important to the growth and survival of MF cancer cells. The study will ...

9. A Registry for United States Patients with Chronic Thromboembolic Pulmonary Hypertension - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

    The purpose of this study is to test a new technology called Next Generation Sequencing (NGS) that may help identify this risk associated with precursor ...